Press
Releases

May 14, 2025 Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update May 13, 2025 Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference April 28, 2025 Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million  February 12, 2025 Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit November 13, 2024 Jade Biosciences to Participate in Upcoming Investor Conferences October 31, 2024 Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement October 24, 2024 Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million August 1, 2024 Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases